ELICHENS
17.12.2020 15:02:09 CET | Business Wire | Press release
Dry ice, frozen carbon dioxide (CO2), maintains the Covid-19 vaccines at very low temperatures. As dry ice warms and changes from a frozen to a gaseous state, it creates an excessive presence of CO2 gas which could affect the health of workers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201217005182/en/
eLichens’ Cranberry NDIR (Non-Dispersive-Infra-Red) CO2 sensor is designed to serve such critical applications. By continuously monitoring CO2 levels and triggering alerts when high thresholds are exceeded our CO2 sensor integrated into the Honeywell BW™ SOLO CO2 product has become essential for workers' protection when manipulating large volumes of dry ice as it prevents toxic health effects such as asphyxia, dizziness, disorientation, fatigue and convulsions.
“We are very proud that eLichens CO2 sensor has been selected by Honeywell for their BW™ SOLO CO2 product to monitor and alert workers in case of unsafe conditions and minimize disruptions throughout the Covid-19 vaccine cold supply chain,” said Wahid Issa, Chief Executive Officer of eLichens.
eLichens’ Cranberry 1-series NDIR sensor is the smallest industrial grade CO2 sensor on the market. It is high performance, dual channel and ultra-low power.
“Working closely with eLichens we quickly saw the technical benefits of their technology and that this was a great fit for our BW™ SOLO CO2 product giving us a sensor that performs in extreme conditions and a reliability that the end user can trust,” said Richard Dunn, Senior Offering Management Leader at Honeywell.
More information about the Honeywell BW™ SOLO at: https://www.honeywellanalytics.com/en/products/BW-Solo
About eLichens (www.elichens.com ):
Founded in December 2014, eLichens mission is to pioneer the Smart Sensor Network to enable Air Quality Sensing Services through its data fusion, cloud models and analytics, for a safer and eco-friendlier environment. The company relies on a portfolio of patents, know-how and skills that enable complete air quality and multi-gas (CO2, LEL, CH4, PM, refrigerants, …) detection solutions, addressing Industrial Safety, Gas Utilities and Smart Home/City markets. eLichens has its headquarters in Grenoble, France with offices in Paris, France and in the Silicon Valley California, USA.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201217005182/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kinaxis Named a Leader in Five 2026 IDC MarketScapes for Worldwide Supply Chain Planning13.11.2026 13:00:00 CET | Press release
Maestro delivers concurrent planning on a single platform across discrete, process, consumer packaged goods and life sciences Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, today announced it has been named a Leader in five 2026 IDC MarketScape vendor assessments for worldwide supply chain planning. The recognition spans the overall market and four industries - discrete industries, process industries, consumer packaged goods and life sciences industries - all served by a single platform, Kinaxis Maestro®, the company's AI-powered supply chain orchestration platform. "Supply chain leaders don't need a better forecast once a month. They need to know what changed this morning, what it means across the business, and what to do about it," said Andrew Bell, Chief Product Officer of Kinaxis. "I believe being named a Leader across five IDC MarketScape vendor assessments, in industries that plan in very different ways, shows that a single concurr
SBC Medical Announces Capital and Business Alliance with NeuroBrain Dynamics to Advance Clinic Profitability Through Medical AI13.11.2026 12:30:00 CET | Press release
Companies to co-develop six medical AI solutions targeting revenue expansion and cost reduction; SBC Medical secures priority sales rights in Japan and South Korea and targets B2B expansion across Asia SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced a strategic capital and business alliance agreement with NeuroBrain Dynamics Inc. (“NBD”), a Taipei-based company dedicated to enterprise generative AI solutions. As part of the agreement executed on November 13, 2026, SBC Medical has made a minority equity investment in NBD. Through this alliance, SBC Medical plans to introduce two complementary suites of generative AI solutions across its network of 287 clinics in Japan and overseas*: “revenue-growth AI,” to elevate average revenue per visit and customer retention through personalized customer guidance, and “cost-reduction AI,
SBC Medical Group Holdings Reports Third Quarter 2026 Financial Results13.11.2026 12:30:00 CET | Press release
Revenue Up 35%, Net Income Attributable to SBC Medical Up 22%, and Adjusted EBITDA1 Up 66% Year-over-Year; Net Income Margin of 27% and Adjusted EBITDA Margin of 47% — Previously Announced Service Fee Revisions and New Clinic Openings Contribute to Revenue Growth and Operating Margin Improvement SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields to medical institutions in Japan and abroad, today announced its consolidated financial results for the third quarter of fiscal year 2026 (the three months ended September 30, 2026) and the three cumulative quarters of fiscal year 2026 (the nine months ended September 30, 2026). Third Quarter 2026 Financial Highlights Total revenues were $59 million, up 35% year-over-year. Income from operations was $26 million, up 66% year-over-year, with an operating margin of 45%. Net income attributable to SBC Medi
Interactive Brokers Offers Eligible Clients Access to the Anthropic, PBC Initial Public Offering13.11.2026 11:00:00 CET | Press release
ADVERTISEMENT This advertisement constitutes an advertisement within the meaning of the Prospectus Regulation and marketing communication within the meaning of MiFID II and is prepared by and in the sole responsibility of Interactive Brokers Ireland Limited, North Dock One, 91/92 North Wall Quay, Dublin 1, D01 H7V7, Ireland, a firm authorized and regulated by the Central Bank of Ireland. Eligible clients of Interactive Brokers Ireland Limited can participate in the offering. Interactive Brokers Ireland Limited, part of Interactive Brokers Group (Nasdaq: IBKR), an automated global broker, today announced that eligible clients can participate in the initial public offering (the “Offering”) of Anthropic, PBC (the “Company”). Through the IBKR platform, eligible clients resident and located in Denmark, Finland, France, Germany, Ireland, the Netherlands, Norway, Spain, and Sweden can review the Offering and submit an application during the offer period, which is open for all eligible clients
Yamaha to Acquire Disguise, Expanding Its Capabilities in Integrated Audio, Video, Lighting and Media13.11.2026 08:00:00 CET | Press release
Acquisition combines Yamaha’s audio expertise with Disguise’s software and media server technologies Yamaha Corporation today announced an agreement to acquire Disguise Technologies Limited (“Disguise”), a London-based provider of software and media server technologies for live and immersive experiences. Yamaha will acquire the company by purchasing all shares in its parent, Butterfly Topco Limited. The acquisition will expand Yamaha’s capabilities beyond audio into integrated audio, video, lighting and media solutions, in line with its strategy to expand beyond hardware into software and services. By combining Yamaha’s audio expertise and global reach with Disguise’s software, technologies and worldwide partner network, the companies will be better positioned to deliver immersive experiences across live entertainment, sports and other venues. Disguise’s technology powers live and immersive experiences worldwide, including tours by Beyoncé and Taylor Swift and venues such as New York’s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom